Indivior (LON:INDV) Trading Up 9.9% - Here's Why

Indivior PLC (LON:INDV - Get Free Report)'s share price traded up 9.9% on Tuesday . The company traded as high as GBX 1,090 ($14.88) and last traded at GBX 1,084 ($14.79). 496,685 shares changed hands during mid-day trading, a decline of 39% from the average session volume of 808,406 shares. The stock had previously closed at GBX 986 ($13.46).

Indivior Stock Performance

The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The firm has a market capitalization of £1.77 billion, a PE ratio of -936.93, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The firm's 50 day moving average price is GBX 944.53 and its 200-day moving average price is GBX 864.18.

Insider Buying and Selling at Indivior

In other Indivior news, insider Juliet Thompson purchased 3,850 shares of the stock in a transaction on Wednesday, June 11th. The shares were bought at an average price of GBX 1,388 ($18.94) per share, for a total transaction of £53,438 ($72,932.99). 3.44% of the stock is currently owned by corporate insiders.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.